Unknown

Dataset Information

0

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.


ABSTRACT: The purpose of this study was to evaluate treatment patterns and outcomes of stereotactic body radiotherapy (SBRT) for centrally located primary non-small cell lung cancer (NSCLC) or lung metastases from the RSSearch(®) Patient Registry, an international, multi-center patient registry dedicated to radiosurgery and SBRT.Eligible patients included those with centrally located lung tumors clinically staged T1-T2 N0, M0, biopsy-confirmed NSCLC or lung metastases treated with SBRT between November 2004 and January 2014. Descriptive analysis was used to report patient demographics and treatment patterns. Overall survival (OS) and local control (LC) were determined using Kaplan-Meier method. Toxicity was reported using the Common Terminology Criteria for Adverse Events version 3.0.In total, 111 patients with 114 centrally located lung tumors (48 T1-T2,N0,M0 NSCLC and 66 lung metastases) were treated with SBRT at 19 academic and community-based radiotherapy centers in the US and Germany. Median follow-up was 17 months (range, 1-72). Median age was 74 years for primary NSCLC patients and 65 years for lung metastases patients (p?

SUBMITTER: Davis JN 

PROVIDER: S-EPMC4443630 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.

Davis Joanne N JN   Medbery Clinton C   Sharma Sanjeev S   Pablo John J   Kimsey Frank F   Perry David D   Muacevic Alexander A   Mahadevan Anand A  

Radiation oncology (London, England) 20150515


<h4>Background</h4>The purpose of this study was to evaluate treatment patterns and outcomes of stereotactic body radiotherapy (SBRT) for centrally located primary non-small cell lung cancer (NSCLC) or lung metastases from the RSSearch(®) Patient Registry, an international, multi-center patient registry dedicated to radiosurgery and SBRT.<h4>Methods</h4>Eligible patients included those with centrally located lung tumors clinically staged T1-T2 N0, M0, biopsy-confirmed NSCLC or lung metastases tr  ...[more]

Similar Datasets

| S-EPMC5999925 | biostudies-literature
| S-EPMC5286804 | biostudies-literature
| S-EPMC7807606 | biostudies-literature
| S-EPMC6524984 | biostudies-literature
| S-EPMC4348495 | biostudies-literature
| S-EPMC5658902 | biostudies-literature
| S-EPMC8996167 | biostudies-literature
| S-EPMC5811977 | biostudies-literature
| S-EPMC7668323 | biostudies-literature
| S-EPMC7867744 | biostudies-literature